Oncocross is an Artificial Intelligence based biotech specializing in drug development.
Oncocross’ service is based on the two AI platform described below:
ONCO AI – is an AI platform to screen optimal indications for drug compound in preclinical or clinical stages and to find the most suitable combination drugs to develop Incrementally Modified Drug (IMD) or orphan drugs, using proprietary human transcriptomic data (RNA expression), disease data, and drug data. Using ONCO AI, we can accelerate drug development process in a shorter time at a lower cost.
ONCOfind AI – is an AI platform to screen and identify the most suitable biomarker for anti-cancer drug compound candidate using proprietary standardized human transcriptomic data of multiple races and various phenotype information of cancer. This platform can also identity the original anatomic site of primary cancer tumor for Carcinoma of Unknown Primary (CUP).
Website english version url:http://oncocross.com/web/index.php
Country of HQ:South Korea
City of HQ:SeongNam
Number of full time employees:18
Equity Capital Raised(Usd) so far:19.37 Mil
Current Investor Lists:10
About company/product in details
Product video url:https://youtu.be/ic_MAGKaTCw
Short description:"Developed a nutrious balanced salad under the concept of""a healthy meal salad"" and deliver to customers within an hour from production base.
Currently, developing service algorithm of mathcing personalized food and nutrition information on the application through data analysis. Operating 5 directly managed stores around Seoul and capital area and 1 production base. 1st merchant store is opening in Magok on November 14th, 2019."
2018 revenue usd:USD 1mil
Estimated 2019 revenue usd:USD 1.7mil
Estimated revenue in 5 years usd:USD 8mil
Risk management plan preparing for the worst scenario:"It is challenge to supply and demand vegetables steadily throughout the year, Himnanda has diversified vegetable-supplied channels for a long period of business.
We have a strategy of expanding distriution of good food into contents, but the most difficulties of franchise is effective control of them. Current franchises have higher rate of failures due to high dependency of people, but HIMNANDA has strategy of managing franchise effectively by combining data based and IT."
Current Fundraising Info
Current stage of this fundraising round:Pre-A
Fundraising goal of this round:USD 2mil
Expected pre-valuation for this round(usd):USD 10mil
Minimum investment:USD 0.1mil
Amount of current commitment for this funding round (usd):USD 50,000
Target Buyer Info
Please write down 10 keywords in detail for your industries (ex, LivecastManagement, Broadcast Recording(VOD), Advertising Statistics):Autonomous Driving, Self-Driving, Advanced Driver Assistance System(ADAS), Automotive Radar, Imaging Radar, Intelligent Transportation System(ITS), Smart City, Dynamic Map, Surveillance, Security
Please write down 5 type of target buyers groups (Restaurants and cafes, Independent stores, Manufactures (Packaged ingredients).):Autonomous Driving OEM, Autonomous Driving NTO(Non Traditional OEM), Autonomous Driving Hardware & Software Platform Company, Ride Sharing / AI / Map company, Surveillance and Security company
Please write down 20 companies that you want to meet to sell your products in US:GM, Ford, Volvo, Tesla, Zoox, Google, Waymo, Apple, Baidu, NVIDIA, Intel, Samsung(Harman), Uber, Lyft, Argo AI, Here, etc.
Please write down 20 companies that you want to meet to sell your products in Asia:BAIC, Brilliance, BYD, Byton, Changan, Chery, Honda, Infiniti, Lexus, Mazda etc.